Alcon Inc. (ALC)
NYSE: ALC · Real-Time Price · USD
75.37
-1.45 (-1.89%)
At close: Oct 7, 2025, 4:00 PM EDT
76.50
+1.13 (1.50%)
After-hours: Oct 7, 2025, 4:51 PM EDT
Alcon Market Cap
Alcon has a market cap or net worth of $37.58 billion as of October 7, 2025. Its market cap has decreased by -21.22% in one year.
Market Cap
37.58B
Enterprise Value
41.44B
1-Year Change
-21.22%
Ranking
Category
Stock Price
$75.37
Market Cap Chart
Since April 9, 2019, Alcon's market cap has increased from $28.35B to $37.58B, an increase of 32.56%. That is a compound annual growth rate of 4.43%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 6, 2025 | 38.22B | -8.85% |
| Dec 30, 2024 | 41.93B | 9.07% |
| Dec 29, 2023 | 38.45B | 14.43% |
| Dec 30, 2022 | 33.60B | -22.39% |
| Dec 30, 2021 | 43.29B | 30.98% |
| Dec 30, 2020 | 33.05B | 18.75% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Apr 9, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 753.98B |
| Johnson & Johnson | 454.31B |
| AbbVie | 413.22B |
| UnitedHealth Group | 326.22B |
| Novo Nordisk | 264.73B |
| AstraZeneca | 264.35B |
| Novartis AG | 256.18B |
| Abbott Laboratories | 234.25B |